|
PF-44740 |
XYLISOL Cassará 0.65% Solución nasal estéril |
2025-06-17 |
|
Laboratorio Pablo Cassará S.R.L. |
Argentina
|
Resco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-44738 |
HYPERSOL B 100, 100 mcg / dosis Suspensión nasal |
2025-06-17 |
|
Laboratorio Pablo Cassará S.R.L. |
Argentina
|
Resco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-44945 |
Eritropoyetina Humana Recombinante 4000 UI/mL solución inyectable |
2015-08-03 |
|
Laboratorio Pablo Cassará S.R.L. |
Argentina
|
Nobifarma |
Avanter, S.A. Avances Terapeuticos |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-45027 |
MOLCASS 400 mcg Polvo liofilizado y solución para uso parenteral |
2020-03-09 |
|
Pablo Cassará S.R.L |
Argentina
|
Nobifarma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-45176 |
ERITROPOYETINA HUMANA RECOMBINANTE 10000 UI/mL solución inyectable |
2015-10-11 |
|
Laboratorio Pablo Cassará S.R.L. |
Argentina
|
Nobifarma |
Avanter, S.A. Avances Terapeuticos |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-45136 |
NEUGRAFIL J/P 300 mcg/1mL Solución Inyectable |
2015-09-27 |
|
Avanter, S.A. Avances Terapeuticos |
Argentina
|
Nobifarma |
Avanter, S.A. Avances Terapeuticos |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-45441 |
NEUMOCORT 200 mcg/dosis Aerosol suspension para inhalación |
2026-01-03 |
|
Laboratorio Pablo Cassará S.R.L. |
Argentina
|
Resco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-45346 |
ERITROPOYETINA HUMANA RECOMBINANTE Pablo Cassará 2000 UI/mL Solución inyectable |
2015-11-24 |
|
Laboratorio Pablo Cassará S.R.L. |
Argentina
|
Nobifarma |
Avanter, S.A. Avances Terapeuticos |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-45623 |
TOBRACAS 300 mg/5 mL Solución para inhalación |
2026-05-21 |
|
Laboratorio Pablo Cassará S.R.L. |
Argentina
|
Resco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-47307 |
MODULCASS 5 % Crema tópica |
2027-05-24 |
|
Laboratorio Pablo Cassará S.R.L. |
Argentina
|
Resco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|